Evidence map›Paper›PMID 40084251›Full record

ArticleInternational journal of medical sciences2025

Genetic variants of

Wei-Chun Weng, Yung-Wei Lin, Chung-Howe Lai, Chia-Yen Lin, Yu-Ching Wen, Lun-Ching Chang, Shun-Fa Yang, Ming-Hsien Chien

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Impact ofInternational journal of medical sciences · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wei-Chun WengDepartment of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
Yung-Wei LinInternational Master/PhD Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Chung-Howe LaiDepartment of Urology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
Chia-Yen LinDivision of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.
Yu-Ching WenDepartment of Urology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Lun-Ching ChangDepartment of Mathematics and Statistics, Florida Atlantic University, Boca Raton, FL, USA.
Shun-Fa YangInstitute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Ming-Hsien ChienGraduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2), which binds with high affinity to numerous RNA transcripts, is known to promote tumorigenesis and metastasis, including in prostate cancer (PCa). Several case-control studies investigated associations between

Indexed as

Neoplasm Recurrence, LocalProstatic NeoplasmsRNA-Binding ProteinsAgedCase-Control StudiesDisease ProgressionGenetic Predisposition to DiseaseGenotypeHumansMaleMiddle AgedNeoplasm InvasivenessPolymorphism, Single NucleotideProstateProstatectomyProstate-Specific AntigenIGF2BP2 protein, humanProstate-Specific AntigenRNA-Binding ProteinsInsulin-like growth factor 2 mRNA-binding protein 2Perineural invasionProstate cancerSingle-nucleotide polymorphism

Identifiers

PMID40084251
PMCPMC11898855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.